Could zapping the brain ease nerve pain in NMOSD?
NCT ID NCT07377305
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a non-invasive brain stimulation device (tTIS) to see if it can safely reduce neuropathic pain in people with neuromyelitis optica spectrum disorder (NMOSD). Twelve participants will receive the stimulation and report their pain levels. The goal is to find a new, drug-free option for chronic nerve pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial temporal interference stimulation (tTIS) device
- What this could lead to
- If it works, this could point toward a drug-free way to reduce chronic nerve pain in NMOSD patients.
- What could go wrong
- This is a very small, early pilot study with only 12 people and no placebo group, so results may not be reliable or apply to others.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMO SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tangdu Hospital
RECRUITINGXi'an, Shaanxi, 710038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a JAK inhibitor tame the immune attack in NMOSD?
- New study uses advanced scans to map brain inflammation over time
- New drug B001 tested for rare autoimmune disease
- Immune cell therapy aimed at autoimmune diseases hits early snag
- Massive Real-World study to track brain and nerve autoimmune disorders
- AI set to revolutionize MS diagnosis and monitoring